Submit or Track your Manuscript LOG-IN

Insilico Screening of Bioactive Phytochemicals against Spike Protein of COVID-19

Insilico Screening of Bioactive Phytochemicals against Spike Protein of COVID-19

Muhammad Hamza Tariq1, Mahjabeen Akram2 and Yasir Sharif3*

1Atta-ur-Rehman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan
2Paediatrics Medicine Unit 1, Services Hospital, Lahore 54000, Pakistan
3Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore-54590, Pakistan

*      Corresponding author:


Coronavirus disease 2019 (COVID-19) is a pandemic and this disease has infected millions of people globally now. COVID-19 is caused by a novel beta coronavirus strain known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Once SARS-CoV-2 manages to enter the body, it identifies and binds to the angiotensin converting enzyme 2 (ACE2) receptors through the binding receptor of Spike Protein (S-protein). The present study aimed to investigate the phytochemicals as potential inhibitors of the binding domain of S protein so that the binding of COVID-19 with ACE2 receptors could be restrained. For this purpose, the library of 2113 phytochemicals was docked against the binding domain of the S-protein. Top ten compounds with maximum binding affinity to the active sites of target protein were further screened for ADMET properties by adopting SwissADME and ADMETsar online servers. The compounds namely Morin, Curcumin, Apigenin, Cedronolactone A and Matairesinol showed acceptable drug-like properties therefore these compounds can be proposed as effective inhibitors, disrupting the S-protein- ACE2 interaction. This study might help in the development of a natural and cost-effective drug against COVID-19. Further, in vivo and in vitro examinations are required to validate our results.

To share on other social networks, click on any share button. What are these?

Pakistan Journal of Zoology


Pakistan J. Zool., Vol. 56, Iss. 4, pp. 1501-2000


Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits

Subscribe Unsubscribe